Clinical Trial Update: Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers

View source ↗

Summary

This clinical trial update outlines an early detection study for pancreatic ductal adenocarcinoma using a biomarker panel, which is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Queen Mary University of London | Conditions: Pancreatic Ductal Adenocarcinoma | Status: ACTIVE_NOT_RECRUITING